Jonathan Webster

Johns Hopkins University — United States

Medicine · Health Sciences

32h-index4.4kcitations186works3.12yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Acute Lymphoblastic Leukemia research(39), Acute Myeloid Leukemia Research(35), Chronic Myeloid Leukemia Treatments(23), Growth Hormone and Insulin-like Growth Factors(19), Pituitary Gland Disorders and Treatments(19)

Publications182 total

Chemotherapy regimens with second generation tyrosine kinase inhibitors for <i>BCR-ABL</i> B-cell acute lymphoblastic leukemia: comparative outcomes and role of allogeneic hematopoietic cell transplantation
Leukemia & lymphoma/Leukemia and lymphoma·2026
Outcomes of adolescent and young adult patients with AML treated on adult versus pediatric protocols
Blood·2025Open Access
Metronomic dose decitabine therapy for TP53 complex karyotype myeloid neoplasms
Blood·2025Open Access
DNMT3A, NPM1, and FLT3-ITD triple-mutated AML has a favorable prognosis in the era of FLT3 inhibitors
Blood·2025· 1 citedOpen Access
Post-allogeneic hematopoietic cell transplantation outcomes are similar after hypomethylating agent/venetoclax and intensive, cytarabine-based remission induction for Acute Myeloid Leukemia when using standardized, contemporary transplant techniques
Blood·2025Open Access
Phase II Results of ECOG-ACRIN EA9152: A multicenter study of liposomal vincristine (L-VCR) or vincristine sulfate (VCR) and venetoclax (VEN) in relapsed or refractory acute lymphoblastic leukemia (ALL) and lymphoblastic lymphoma (LL)
Blood·2025Open Access
Cell-free DNA screening results by stage of maternal malignancy
American Journal of Obstetrics & Gynecology MFM·2025
Efficacy and safety of blinatumomab for CD19 + acute leukemias in patients historically excluded from clinical trials due to comorbidities
Leukemia Research·2025Open Access
Empowering Communities: UEA's Anchor Institute Role in Fostering ‘Curated Communities’ as part of an ICS
International Journal of Integrated Care·2025Open Access
Clinical and molecular characterization of TP53-mutant acute lymphoblastic leukemia in adults
Blood Cancer Journal·2025· 4 citedOpen Access
Intensive chemotherapy vs venetoclax/hypomethylating agents for patients aged 60 to 75 years with favorable, NPM1-mutated AML
Blood Neoplasia·2025· 1 citedOpen Access
Improved outcomes of acute lymphoblastic leukemia after allogeneic blood or marrow transplantation with high-dose post-transplantation cyclophosphamide in the era of more effective pre-transplant therapy
Haematologica·2025· 1 citedOpen Access
Abstract 1170: Decitabine (DAC) induces a DNA damage response (DDR) and synergizes with replication checkpoint inhibitors in acute myeloid leukemia (AML)
Cancer Research·2025
Norfolk Initiative for Coastal and Rural Health Equalities (NICHE)
International Journal of Integrated Care·2025Open Access
Recognition, prevention, and management of adverse events associated with asparaginase / pegaspargase treatment of acute lymphoblastic leukemia in adults: consensus of an expert panel
Haematologica·2025· 3 citedOpen Access
Acute Lymphoblastic Leukemia (ALL) Outcomes after Allogeneic Blood or Marrow Transplantation (alloBMT) with High-Dose Post-Transplantation Cyclophosphamide (PTCy) in the Era of More Effective Pre-Transplant Therapy
Blood·2024Open Access
Efficacy and Tolerability of Blinatumomab in Clinical Trial Ineligible Patients with CD19+ Leukemias
Blood·2024· 1 citedOpen Access
Acute Lymphoblastic Leukemia, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology
Journal of the National Comprehensive Cancer Network·2024· 44 cited
Developing critical enquiry, capacity, capability and confidence in the health and care workforce
British Journal of Nursing·2024
A phase 1 trial of venetoclax in combination with liposomal vincristine in patients with relapsed or refractory B‐cell or T‐cell acute lymphoblastic leukemia: Results from the ECOG‐ACRIN EA9152 protocol
eJHaem·2024· 3 citedOpen Access
page 1 of 10Next →

Frequent Co-authors

Ivana Gojo(9), Mark J. Levis(8), Gabrielle T. Prince(7), Amy E. DeZern(7), B. Douglas Smith(7), Leo Luznik(4), G. Piscitelli(3), Carlo Ferrari(3), M. F. Scanlon(3), Pier Giorgio Crosignani(3), Kim Manley(3), Joshua F. Zeidner(3), Benjamin G. Vincent(3), Matthew C. Foster(3), Catherine C. Coombs(3), Katarzyna Jamieson(3), Jonathan S. Serody(3), Keith W. Pratz(3), Amanda L. Blackford(3), Ravi Varadhan(3)